Alma Dubuc

Alma Dubuc

Auto-generated profile, based on publicly available information

Alma Dubuc

Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA; École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Université de Lyon, 69342 Lyon Cedex 07, France; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ALAlex J. Lee
Alex J. Lee
ADAlma Dubuc
Alma Dubuc
MKMichael Kunst
Michael Kunst
SYShenqin Yao
Shenqin Yao
NLNicholas Lusk
Nicholas Lusk
RAReza Abbasi-Asl
Reza Abbasi-Asl
Spatial transcriptomics offers unique opportunities to define the spatial organization of tissues and organs, such as the mouse brain. We address a key bottleneck in the analysis of organ-scale spatial transcriptomic data by establishing a workflow for self-supervised spatial domain detection that is scalable to multimillion-cell datasets. This workflow uses a self-supervised framework for learning latent representations of tissue spatial domains or niches. We use an encoder-decoder architecture, which we named CellTransformer, to hierarchically learn higher-order tissue features from lower-level cellular and molecular statistical patterns. Coupling our representation learning workflow with minibatched GPU-accelerated clustering algorithms allows us to scale to multi-million cell MERFISH datasets where other methods cannot. CellTransformer is effective at integrating cells across tissue sections, identifying domains highly similar to ones in existing ontologies such as Allen Mouse Brain Common Coordinate Framework (CCF) while allowing discovery of hundreds of uncataloged areas with minimal loss of domain spatial coherence. CellTransformer domains recapitulate previous neuroanatomical studies of areas in the subiculum and superior colliculus and characterize putatively uncataloged subregions in subcortical areas, which currently lack subregion annotation. CellTransformer is also capable of domain discovery in whole-brain Slide-seqV2 datasets. Our workflows enable complex multi-animal analyses, achieving nearly perfect consistency of up to 100 spatial domains in a dataset of four individual mice with nine million cells across more than 200 tissue sections. CellTransformer advances the state of the art for spatial transcriptomics by providing a performant solution for the detection of fine-grained tissue domains from spatial transcriptomics data.

16 December 2025 in bioRxiv
Verified
Preprint
Open access
NJNelson J. Johansen
Nelson J. Johansen
YFYuanyuan Fu
Yuanyuan Fu
MSMatthew Schmitz
Matthew Schmitz
ADAlma Dubuc
Alma Dubuc
NKNiklas Kempynck
Niklas Kempynck
TBTrygve E. Bakken
Trygve E. Bakken
The basal ganglia (BG) are conserved brain regions essential for motor control, learning, emotion, and cognition, and are implicated in neurological and psychiatric disease. Yet a unified cross-species taxonomy of BG cell types is lacking, limiting translation of BG circuit mechanisms, interpretation of human genetic risk, and development of cell type-targeted tools. We present a multiomic consensus atlas of 1.8 million nuclei from human, macaque, and marmoset spanning eight BG structures. Integrating cross-species gene expression, open chromatin, and spatial profiling enables definition of conserved and divergent cell types. Alignment to existing mouse and human atlases identifies 61 homologous cell types conserved over 80 million years. We identify a STRd D2 StrioMat Hybrid medium spiny neuron (MSN) type with molecular, electrophysiological, and morphological features that clarify hybrid MSN identities. Comparative cis-regulatory analysis reveals conserved sequence grammars that encode cell identity and inform viral targeting strategies, providing a foundational resource for BG evolution, function, and disease.

17 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GHGuillaume Huguet
Guillaume Huguet
TRThomas Renne
Thomas Renne
CPCécile Poulain
Cécile Poulain
ADAlma Dubuc
Alma Dubuc
KKKuldeep Kumar
Kuldeep Kumar
SJSébastien Jacquemont
Sébastien Jacquemont
Genomic Copy Number Variants (CNVs) that increase risk for neurodevelopmental disorders are also associated with lower cognitive ability in general population cohorts. Studies have focussed on a small set of recurrent CNVs, but burden analyses suggested that the vast majority of CNVs affecting cognitive ability are too rare to reach variant-level association. As a result, the full range of gene-dosage-sensitive biological processes linked to cognitive ability remains unknown. To investigate this issue, we identified all CNVs >50 kilobases in 258k individuals from 6 general population cohorts with assessments of general cognitive abilities. We performed a CNV-GWAS and functional burden analyses, which tested 6502 gene-sets defined by tissue and cell-type transcriptomics as well as gene ontology disrupted by all rare coding CNVs. CNV-GWAS identified a novel duplication at 2q12.3 associated with higher performance in cognitive ability. Among the 864 gene-sets associated with cognitive ability, only 11% showed significant effects for both deletions and duplication. Accordingly, we systematically observed negative correlations between deletion and duplication effect sizes across all levels of biological observations. We quantified the preferential effects of deletions versus duplication using tagDS, a new normalized metric. Cognitive ability was preferentially affected by cortical, presynaptic, and negative-regulation gene-sets when duplicated. In contrast, preferential effects of deletions were observed for subcortical, post-synaptic, and positive-regulation gene-sets. A large proportion of gene-sets assigned to non-brain organs were associated with cognitive ability due to low tissue specificity genes, which were associated with higher sensitive to haploinsufficiency. Overall, most biological functions associated with cognitive ability are divided into those sensitive to either deletion or duplications.

7 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAlex Jihun Lee
Alex Jihun Lee
ADAlma Dubuc
Alma Dubuc
MKMichael Kunst
Michael Kunst
SYShenqin Yao
Shenqin Yao
NLNicholas Lusk
Nicholas Lusk
RAReza Abbasi-Asl
Reza Abbasi-Asl
Technologies such as spatial transcriptomics offer unique opportunities to define the spatial organization of the mouse brain. We developed an unsupervised training scheme and novel transformer-based deep learning architecture to detect spatial domains in mouse whole-brain spatial transcriptomics data. Our model learns local representations of molecular and cellular statistical patterns. These local representations can be clustered to identify spatial domains within the brain from coarse to fine-grained. Discovered domains are spatially regular, even with several hundreds of spatial clusters. They are also consistent with existing anatomical ontologies such as the Allen Mouse Brain Common Coordinate Framework version 3 (CCFv31) and can be visually interpreted at the cell type or transcript level. We demonstrate our method can be used to identify previously uncatalogued subregions, such as in the midbrain, where we uncover gradients of inhibitory neuron complexity and abundance. We apply our method to a separate multi-animal whole-brain spatial transcriptomic dataset and observe that inclusion of both sagittal and coronal tissue slices in region identification improves correspondence of spatial domains to CCF.

8 April 2026 in Cell Genomics
Verified
Journal Article
Open access
ADAlma Dubuc
Alma Dubuc
TRThomas Renne
Thomas Renne
GHGuillaume Huguet
Guillaume Huguet
SJSébastien Jacquemont
Sébastien Jacquemont
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski
Genetic association studies have identified numerous genes harboring protein-disrupting variants in individuals with profound autism, but identifying convergent points of vulnerability remains challenging. We discuss how brain transcriptomic resources help decode the cellular consequences of these rare gene-disrupting variants. The functional interpretation of genetic associations has largely relied on gene ontologies and protein-interaction networks, with newer approaches leveraging single-cell expression to estimate cellular enrichment. However, the broad expression of many autism-associated genes confounds cell-type-specific effects. We therefore propose a framework quantifying the trade-off between a gene's cell-type specificity and sensitivity. The limited overlap between genetic associations and transcriptomic alterations in autistic brains prompts a discussion about causality. We examine whether foundation models linking genetic variation to cell-type transcriptomes could clarify the cellular functions affected by autism-associated variants. By combining experimental perturbations, artificial-intelligence-driven inference, and postmortem validation, we propose a unifying mechanistic framework for rare-variant liability in autism.

13 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
TRThomas Renne
Thomas Renne
FBFlorian Benitière
Florian Benitière
CPCecile Poulain
Cecile Poulain
ADAlma Dubuc
Alma Dubuc
VBVincent Bourque
Vincent Bourque
SJSebastien Jacquemont
Sebastien Jacquemont
Autism Spectrum Disorders (ASD) can result from rare genetic variants interfering with brain development. Whether their effects converge on specific cortical cell types remains unresolved. Previous studies have focused on a narrow set of high-confidence ASD (hcASD) genes, which were enriched in neuronal cell types during prenatal development. By contrast, studies of postnatal cerebral cortex have repeatedly associated ASD with transcriptional changes in both neurons and glia. To comprehensively map ASD genetic liability across cortical cell types, we conducted a functional genetic burden analysis with 124,416 individuals, including ASD probands and unaffected family members. We examined six classes of rare gene-disrupting variants aggregated across a complete spectrum of transcriptomic cell types of the human prefrontal cortex throughout development. We show that cellular liabilities in ASD delineate a broad and developmentally dynamic architecture. Likewise, we uncover high dependency on classes of variants with Loss-of-Function (LoF) and de novo linked to prenatal cells, while duplications, missense, and inherited variants increase liability through postnatal and glial cell types. Notably, inherited LoF variants uncover the contribution of microglia to ASD liability, also supported by transcriptomic evidence from postmortem ASD brains. Finally, we show that overall, variants disrupting genes differentially expressed in postmortem ASD brains significantly contribute to ASD liability, demonstrating convergence between disrupted transcriptomes and genetic liability. Together, our study offers an integrative, cell-type-aware framework for interpreting ASD risk genetics.